Chromatin landscapes and genetic risk in systemic lupus.
Chromatin landscapes and genetic risk in systemic lupus.
复制标题
DOI:
10.1186/s13075-016-1169-9
复制
发表时间:
2016-12-01
影响因子:
4.9
通讯作者:
Jarvis JN
中科院分区:
文献类型:
--
作者:
Hui-Yuen JS;Zhu L;Wong LP;Jiang K;Chen Y;Liu T;Jarvis JN
Systemic lupus erythematosus (SLE) is a multi-system, complex disease in which the environment interacts with inherited genes to produce broad phenotypes with inter-individual variability. Of 46 single nucleotide polymorphisms (SNPs) shown to confer genetic risk for SLE in recent genome-wide association studies, 30 lie within noncoding regions of the human genome. We therefore sought to identify and describe the functional elements (aside from genes) located within these regions of interest. We used chromatin immunoprecipitation followed by sequencing to identify epigenetic marks associated with enhancer function in adult neutrophils to determine whether enhancer-associated histone marks were enriched within the linkage disequilibrium (LD) blocks encompassing the 46 SNPs of interest. We also interrogated available data in Roadmap Epigenomics for CD4+ T cells and CD19+ B cells to identify these same elements in lymphoid cells. All three cell types demonstrated enrichment of enhancer-associated histone marks compared with genomic background within LD blocks encoded by SLE-associated SNPs. In addition, within the promoter regions of these LD blocks, all three cell types demonstrated enrichment for transcription factor binding sites above genomic background. In CD19+ B cells, all but one of the LD blocks of interest were also enriched for enhancer-associated histone marks. Much of the genetic risk for SLE lies within or near genomic regions of disease-relevant cells that are enriched for epigenetic marks associated with enhancer function. Elucidating the specific roles of these noncoding elements within these cell-type-specific genomes will be crucial to our understanding of SLE pathogenesis. The online version of this article (doi:10.1186/s13075-016-1169-9) contains supplementary material, which is available to authorized users.
登录
查看更多内容
DOI:
10.1002/art.39499
发表时间:
2016-04
期刊:
Arthritis & rheumatology (Hoboken, N.J.)
影响因子:
--
作者:
Ichinose K;Ushigusa T;Nishino A;Nakashima Y;Suzuki T;Horai Y;Koga T;Kawashiri SY;Iwamoto N;Tamai M;Arima K;Nakamura H;Obata Y;Yamamoto K;Origuchi T;Nishino T;Kawakami A;Tsokos GC
通讯作者:
Tsokos GC
影响因子:
64.5
作者:
Benayoun BA;Pollina EA;Ucar D;Mahmoudi S;Karra K;Wong ED;Devarajan K;Daugherty AC;Kundaje AB;Mancini E;Hitz BC;Gupta R;Rando TA;Baker JC;Snyder MP;Cherry JM;Brunet A
通讯作者:
Brunet A
影响因子:
5.8
作者:
Johnson, Andrew D.;Handsaker, Robert E.;de Bakker, Paul I. W.
通讯作者:
de Bakker, Paul I. W.
DOI:
10.1196/annals.1423.015
发表时间:
2007-01-01
期刊:
AUTOIMMUNITY, PT B: NOVEL APPLICATIONS OF BASIC RESEARCH
影响因子:
--
作者:
Cervino, Alessandra C. L.;Tsinoremas, Nicholas E.;Hoffman, Robert W.
通讯作者:
Hoffman, Robert W.
影响因子:
5.8
作者:
Dozmorov MG;Dominguez N;Bean K;Macwana SR;Roberts V;Glass E;James JA;Guthridge JM
通讯作者:
Guthridge JM